Search by Drug Name or NDC
NDC 50090-5573-00 Hydroxychloroquine sulfate 200 mg/1 Details
Hydroxychloroquine sulfate 200 mg/1
Hydroxychloroquine sulfate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is HYDROXYCHLOROQUINE SULFATE.
MedlinePlus Drug Summary
Hydroxychloroquine is used to prevent and treat acute attacks of malaria in adults and children weighing more than 31 kg (68 lbs). It is also used to treat discoid lupus erythematosus (DLE; a chronic inflammatory condition of the skin) or systemic lupus erythematosus (SLE or lupus; an autoimmune disease in which the immune system attacks healthy parts of the body such as joints, skin, blood vessels, and organs) and rheumatoid arthritis. Hydroxychloroquine is in a class of drugs called antimalarials and is also an antirheumatic drug. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.
Related Packages: 50090-5573-00Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Hydroxychloroquine
Product Information
| NDC | 50090-5573 |
|---|---|
| Product ID | 50090-5573_8ca0749d-9855-48cd-bbcc-f28a24fd9513 |
| Associated GPIs | |
| GCN Sequence Number | 009580 |
| GCN Sequence Number Description | hydroxychloroquine sulfate TABLET 200 MG ORAL |
| HIC3 | W4A |
| HIC3 Description | ANTIMALARIAL DRUGS |
| GCN | 42940 |
| HICL Sequence Number | 004151 |
| HICL Sequence Number Description | HYDROXYCHLOROQUINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Hydroxychloroquine sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Hydroxychloroquine sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | HYDROXYCHLOROQUINE SULFATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Antimalarial [EPC], Antirheumatic Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040657 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5573-00 (50090557300)
| NDC Package Code | 50090-5573-0 |
|---|---|
| Billing NDC | 50090557300 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5573-0) |
| Marketing Start Date | 2021-06-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |